ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 135

The Blood-CSF-Barrier in SLE: Volume and Blood Flow of the Choroid Plexus and Periventricular Tissue Abnormality Gradients

Mark DiFrancesco, Elizabeth Wilson and Hermine Brunner, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Friday, March 20, 2026

Title: Posters: Genetics and Pathogenesis II

Session Time: 6:00PM-7:00PM

Background/Purpose: SLE leads to vascular compromise in multiple organs, including brain, leading to parenchymal infiltration.  We have demonstrated increased permeability of the blood-brain-barrier (BBB) in SLE. A murine SLE study found infiltrates in CSF with intact BBB, driving inquiry of blood-CSF barriers (BCSFB) including choroid plexus (CP). The CP has fenestrated capillaries and an epithelium regulating exchange with ventricular CSF. Compromise of the BCSFB may be pathogenic for multiple sclerosis (MS) since MRI reveals periventricular gradients of T1 abnormality.  Studies of the BCSFB in humans with SLE are lacking.  We investigate alteration of the BCSFB in SLE and MS including CP volume and blood flow, and periventricular gradients of abnormality of normal-appearing white matter (NAWM).  We include MS patients as positive controls to explore differences between autoimmune conditions. 

Methods: Preliminary analysis included 18 SLE (15F, 17.4 (4.2) yrs), 10 MS (9F, 19.2 (3.5) yrs), and 35 healthy controls (HC, 25F, 19.5 (4.3) yrs).  MRI included quantitative susceptibility mapping (QSM) and SyMRI (relaxometry, myelin concentration (MyC), tissue segmentation).  ITK-SNAP provided ventricle segmentation iteratively dilated to make 50, 1-mm-thick, zones in NAWM (Fig. 1D). We extracted mean values of T1, T2, proton density (PD), MyC, and susceptibility per zone.  A linear fit of HC values: intercept + sex + age + age^2, provided reference to describe deviations of SLE and MS values from HC as z-scores.  We compared mean z-scores for MS and SLE vs. periventricular distance.  We assessed CP volume and perfusion dynamics via arterial spin labeling (ASL). ASCHOPLEX segmented the CP.  Dynamic perfusion signal, fitted to a model, provided arrival time and blood flow at the CP.  We compared group volume, arrival time, and blood flow.

Results: T1 was elevated vs. HC for MS and SLE.  MS had a gradient in T1, lacking in SLE. T2 had a similar pattern of abnormality.  PD was elevated at the surface for both SLE and MS, but MS was more elevated with a steeper gradient (Fig. 1).  MyC was diminished for both groups with greater abnormality for MS at the surface with steeper gradient.  Susceptibility had a pattern like myelin for MS, but SLE showed an increase at middle distances (Fig. 2).  CP volume, as % parenchymal volume, was significantly greater for SLE vs. HC or MS groups (Fig.3).  Arrival time and blood flow did not differ significantly between groups. 

Conclusion: Our results indicate abnormality of all relaxometry and susceptibility metrics close to the ventricular surface for MS patients with gradients toward HC values (z~0) with increasing distance.  This expands published findings for T1 in MS.  SLE also exhibits abnormality throughout NAWM, but some metrics (myelin, T1, T2, PD) have near normal values close to the ventricles with gradients of opposite direction to MS.  Such findings might suggest that SLE and MS have different mechanisms for infiltration.  We observed significantly increased CP volume for SLE but not for MS, suggesting differences in pathophysiology. Evidence for a CP route of brain infiltration could realign phenotyping of SLE and MS and drive targeted therapies.

Figure 1Supporting image 1Periventricular gradients of abnormality (mean z-score of deviation from healthy control references) of A) T1, B) T2, and C) Proton Density. Shaded areas depict standard error. D) illustrates 1 mm thick zones at 5 mm intervals from the ventricular surface (green area).

Figure 2Supporting image 2Periventricular gradients of abnormality (z-score of deviation from healthy control references) of A) Myelin Concentration, B) Susceptibility, and C) quantitative anisotropy. D) shows ChP flow dynamics. Shaded areas depict standard error.

Figure 3Supporting image 3Choroid Plexus volume as percent of brain parenchymal volume. comparisons. Left: mean by group. Right: z-score of deviation from HC. Error bars depict standard error.


Disclosures: M. DiFrancesco: None; E. Wilson: None; H. Brunner: None.

To cite this abstract in AMA style:

DiFrancesco M, Wilson E, Brunner H. The Blood-CSF-Barrier in SLE: Volume and Blood Flow of the Choroid Plexus and Periventricular Tissue Abnormality Gradients [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/the-blood-csf-barrier-in-sle-volume-and-blood-flow-of-the-choroid-plexus-and-periventricular-tissue-abnormality-gradients/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-blood-csf-barrier-in-sle-volume-and-blood-flow-of-the-choroid-plexus-and-periventricular-tissue-abnormality-gradients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology